August 1: Shorts Pile In, Earnings Season Heats Up
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Bears Take Aim at Distressed Names
Short sellers pushed hard into several names today. CHWY now has 82.4% of its free float sold short. HTZ sits even higher at 84.6%. Both stocks are drawing heavy Reddit attention. A squeeze risk is rising fast. SOC saw the biggest weekly move — short interest jumped 11 points to 43.7% of free float. Borrowing shares is nearly impossible there. GRPN is up 96% in three months yet shorts keep pressing, with SI % FF now at 74.3%. Options flow backs the bearish thesis. SNDK — up 412% year-to-date — tops the negative bets table. MU draws heavy options volume on both sides ahead of earnings, a sign of high tension.
Earnings Week in Focus
A major earnings week begins today. MAR reports this morning on travel demand. AMGN and BKNG report Tuesday after the close. Booking at $150bn market cap will give the clearest read on global travel spending. REGN drew fresh analyst upgrades today. Its average target climbed to $833.54. Nine of 17 analysts rate it a Buy.
Enbridge Takes a Legal Hit
Michigan's Supreme Court rejected a pipeline permit for ENB under the Great Lakes today. The ruling blocks a key segment of the Line 5 pipeline. This is a material legal setback for the Canadian energy giant and could weigh on its US operations.
Insider Watch
Charles Schwab sold nearly $20M in SCHW shares between July 24–29. His daughter filed a $2.4M sale on July 28. That cluster of family selling in a stock that has run hard this year is worth watching closely.
Stocks in this article
How this article was generated
- Generated
- 1 Aug 2026, 16:50
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.